NovaBay Pharmaceuticals’ Neutrox® Product Line Receives CE Mark and ISO Certification for the European Union
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova® lid and lash hygiene in the domestic eye care market, announces that its Neutrox® product line has received the CE mark, clearing the way for this product to be sold in European Union and certain other countries, and ISO 13485 certification, satisfying a critical step in European approval process. “It’s gratifying to report that our N
